Kai Zhang

Hecom (Beijing) Technology Co. Ltd. provides software-as-a-service cloud services and other digital solutions for engineering project management and customer relationship management to enterprise-level customers in construction engineering, equipment manufacturing, and fast moving consumer goods industries. The company was founded by Xue Chen Liu on January 9, 2009 and is headquartered in Beijing, China.

Beijing Daxing Investment Group Co. Ltd. engages in the provision of investment services. Its business scope includes asset investment; investment management, and investment consulting; construction general contracting, professional contracting, and labor subcontracting; real estate development; property management; hotel management; and landscaping management. The company was founded on March 5, 2015 and is headquartered in Beijing, China.

Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China.

Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China.